While vital progress has been made, much work still needs to be done to defeat this lethal cancer affecting 20,000 children in the United States.
- There are no pre-clinical models that reflect the spectrum of molecular causes of LGG
- The small number of LGG cell lines that currently exist limits the ability to develop new drugs and test new drug combinations
With your support, Imagine An Answer will be able to help Dr. Raabe and his team keep up the momentum towards the next milestones in their efforts to cure LGG.
Specifically, with your help, Dr. Raabe and his team will be able to:
- Develop better, high fidelity models of pediatric LGG
- Use these models as well as the imperfect existing cell lines to test new drugs and drug combinations, with the goal of providing the rationale needed to initiate clinical trials for patients with recurrent LGG